A doctor-led consultation can help determine whether Wegovy or another treatment is suitable based on your BMI, medical history, current medicines, previous treatment and long-term health goals
No, frequent urination is not listed as a common side effect in FDA prescribing information for semaglutide (Ozempic, Wegovy)
This approach ensures that GLP-1 therapy is tailored to those most likely to benefit from improved metabolic health, weight reduction, and reduced risk of other health conditions such as cardiovascular issues and blood sugar imbalances
PlexusDx patients who stay on compounded semaglutide maintain their weight loss and metabolic improvements long-term
Conclusions Among adults with HIV on ART and lipohypertrophy, semaglutide (GLP-1) slowed DNA methylation aging across PCGrimAge, PhenoAge, DunedinPACE, and organ clocks, while IC was unchanged